Terms: = Head and neck cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
16 results:
1. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing map3k1 and activating autophagy.
Dai L; Zhang W; Wu X; Zhou S
J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer.
Carper MB; Goel S; Zhang AM; Damrauer JS; Cohen S; Zimmerman MP; Gentile GM; Parag-Sharma K; Murphy RM; Sato K; Nickel KP; Kimple RJ; Yarbrough WG; Amelio AL
Neoplasia; 2022 Jul; 29():100799. PubMed ID: 35504112
[TBL] [Abstract] [Full Text] [Related]
3. Apigenin Inhibits Proliferation, Migration, and Invasion of Human Tongue Carcinoma Tca8113 Cells Through Regulating the MAPK Signaling Pathways.
Xuan YZ; Xu LZ; Jin CR; Yang KJ
Curr Mol Med; 2021; 21(8):690-697. PubMed ID: 33092506
[TBL] [Abstract] [Full Text] [Related]
4. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
[TBL] [Abstract] [Full Text] [Related]
5. Identification of the risk factors of the thyroid cancer by using logit model in Lahore.
Asif F; Noor-Ul-Amin M; Ahmad MR
Pak J Pharm Sci; 2018 Nov; 31(6):2391-2396. PubMed ID: 30473509
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q
BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563
[TBL] [Abstract] [Full Text] [Related]
8. MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and map3k1.
Zang WQ; Yang X; Wang T; Wang YY; Du YW; Chen XN; Li M; Zhao GQ
World J Gastroenterol; 2015 May; 21(19):5867-76. PubMed ID: 26019450
[TBL] [Abstract] [Full Text] [Related]
9. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
[TBL] [Abstract] [Full Text] [Related]
10. [The distribution of the pre-cancerous condition and pathological changes of esophageal cancer of the community residents in high-incidence area].
Zhao DL; Li HQ; Ji P; Zhou RX; Lei FH; Diao YT; Li H; Yang YF; Zhou YZ; Wang Y; Yin C; Fang XQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 May; 42(5):345-8. PubMed ID: 18844086
[TBL] [Abstract] [Full Text] [Related]
11. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin.
Yan C; Jamaluddin MS; Aggarwal B; Myers J; Boyd DD
Mol Cancer Ther; 2005 Feb; 4(2):233-41. PubMed ID: 15713895
[TBL] [Abstract] [Full Text] [Related]
12. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract] [Full Text] [Related]
13. 5-Fluorouracil suppression of NF-KappaB is mediated by the inhibition of IKappab kinase activity in human salivary gland cancer cells.
Azuma M; Yamashita T; Aota K; Tamatani T; Sato M
Biochem Biophys Res Commun; 2001 Mar; 282(1):292-6. PubMed ID: 11264006
[TBL] [Abstract] [Full Text] [Related]
14. All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways.
Lee HY; Walsh GL; Dawson MI; Hong WK; Kurie JM
J Biol Chem; 1998 Mar; 273(12):7066-71. PubMed ID: 9507016
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Simon C; Goepfert H; Boyd D
Cancer Res; 1998 Mar; 58(6):1135-9. PubMed ID: 9515796
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract] [Full Text] [Related]
